Real-world comparative outcomes of glucagon like peptide-1 receptor agonists and bariatric surgery in inflammatory bowel disease: A multi-center cohort study
Obesity Medicine · 2026-07 · 62 · 100727
DOI: 10.1016/j.obmed.2026.100727 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Obesity Medicine, 2026-07. Verfasst von Joshua Chen und 6 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chen, J., Patel, R., Mikati, H., Mangray, S., Salluzzo, J., Bickston, S. J., & Tariq, R. (2026). Real-world comparative outcomes of glucagon like peptide-1 receptor agonists and bariatric surgery in inflammatory bowel disease: A multi-center cohort study. Obesity Medicine, 62, 100727. https://doi.org/10.1016/j.obmed.2026.100727
Vancouver
Chen J, Patel R, Mikati H, Mangray S, Salluzzo J, Bickston SJ, et al. Real-world comparative outcomes of glucagon like peptide-1 receptor agonists and bariatric surgery in inflammatory bowel disease: A multi-center cohort study. Obesity Medicine. 2026;62:100727. doi:10.1016/j.obmed.2026.100727
BibTeX
@article{Chen2026,
author = {Chen, Joshua and Patel, Riya and Mikati, Husam and Mangray, Sasha and Salluzzo, Jennifer and Bickston, Stephen J. and Tariq, Raseen},
title = {Real-world comparative outcomes of glucagon like peptide-1 receptor agonists and bariatric surgery in inflammatory bowel disease: A multi-center cohort study},
journal = {Obesity Medicine},
year = {2026},
volume = {62},
pages = {100727},
doi = {10.1016/j.obmed.2026.100727}
}
EUVIMED